Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT01979952 · COMPLETED
Trial details
- NCT number
- NCT01979952
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-26
- Primary completion
- 2016-10-27
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.